Cleared Traditional

K974363 - BECTON DICKINSON BLUNT PLASTIC CANNULA

K974363 is an FDA 510(k) clearance for BECTON DICKINSON BLUNT PLASTIC CANNULA, manufactured by Bd Becton Dickinson Vacutainer Systems Preanalytic. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 196-day FDA review.

K974363 · Bd Becton Dickinson Vacutainer Systems Preanalytic · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1998
Decision
196d
Days
Class 2
Risk

K974363 is an FDA 510(k) clearance for the BECTON DICKINSON BLUNT PLASTIC CANNULA. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Franklin Lakes, US). The FDA issued a Cleared decision on June 3, 1998 after a review of 196 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Bd Becton Dickinson Vacutainer Systems Preanalytic devices

FDA 510(k) Submission Details - K974363

510(k) Number K974363 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 19, 1997
Decision Date June 03, 1998
Days to Decision 196 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d slower than avg
Panel avg: 129d · This submission: 196d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 494
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K974363.
VACUETTE MULTIPLE SAMPLE LUER ADAPTER
K981619 · Greiner Meditech, Inc. · Jul 1998
WORLDWIDE MEDICAL TECHNOLOGIES INTRACERVICAL BLOCK NEEDLE, MODEL TBD
K982097 · Worldwide Medical Technologies, LLC · Jun 1998
SHARPTRACK REUSABLE SHARPS CONTAINER
K981184 · Bfi- Medical Waste Systems · Jun 1998
EXEL AVF SINGLE NEEDLE
K963658 · Exel Intl. · May 1998
RESHEATHER DEVICE-METAL OR PLASTIC, RESHEATER/ NEEDLE HOLDER DEVICE-PLASTIC
K972705 · Sage Products, Inc. · Apr 1998
MANAN GALACTOGRAPHY KIT
K980227 · Medical Device Technologies, Inc. · Apr 1998